...
首页> 外文期刊>Trends in Cardiovascular Medicine >The functions of plasminogen in cardiovascular disease.
【24h】

The functions of plasminogen in cardiovascular disease.

机译:纤溶酶原在心血管疾病中的功能。

获取原文
获取原文并翻译 | 示例
           

摘要

Plasminogen (Plg) and its derivative serine protease, plasmin, together with the activators, inhibitors, modulators, and substrates of the Plg network, are postulated to regulate a wide variety of biologic responses that could influence cardiovascular disease. The development of Plg-deficient mice has provided an incisive approach to test these proposed functions in vivo. Several different models of atherosclerosis, restenosis, aneurysm, and thrombosis have been analyzed in these mice and have demonstrated profound effects of Plg on these events as well as on the inflammatory response, which contributes to these cardiovascular diseases. Plasmin (ogen) may influence the progression of cardiovascular diseases through its degradation of matrix proteins, including fibrin; its activation of matrix metalloproteinases; its regulation of growth factor and chemokine pathways; or its influence on directed cell migration. Dissection of these mechanisms represents a future challenge toward understanding the roles of Plg in vivo.
机译:假定纤溶酶原(Plg)及其衍生的丝氨酸蛋白酶,纤溶酶以及Plg网络的激活剂,抑制剂,调节剂和底物可调节可能影响心血管疾病的多种生物学反应。 Plg缺陷小鼠的发展提供了一种在体内测试这些拟议功能的精确方法。已在这些小鼠中分析了几种不同的动脉粥样硬化,再狭窄,动脉瘤和血栓形成模型,这些模型已证明Plg对这些事件以及对导致这些心血管疾病的炎症反应具有深远的影响。血浆蛋白原可能通过降解包括纤维蛋白在内的基质蛋白来影响心血管疾病的进展;它激活基质金属蛋白酶;其对生长因子和趋化因子途径的调节;或其对定向细胞迁移的影响。这些机制的解剖代表了理解Plg体内作用的未来挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号